In a highly challenging case, a 55-year-old woman suffering from a complex renal tumor located dangerously close to the ...

When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

1. Huang J. Disitamab vedotin plus tislelizumab as nephron-sparing therapy for high-risk upper tract urothelial carcinoma: The phase II DISTINCT-I trial. Presented at: ESMO 2025 Congress; October ...

Third quarter performance driven by strong portfolio royalty revenue growth of 47%2025 full year revenue guidance increased to $225 million - ...

In A Nutshell • A pig kidney with just one genetic modification functioned in a human for 61 days before being removed as ...

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...

Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...

HOUSTON -- Two commonly used kidney function tests had a large degree of disagreement and were linked with serious health outcomes in patients with chronic kidney disease (CKD), according to a ...

The Liberation From Acute Dialysis (LIBERATE-D) randomized clinical trial tested the value of a conservative vs conventional hemodialysis strategy on recovery of kidney function in stable patients ...